Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
2021 · Med · 199 citations
https://doi.org/10.1016/j.medj.2021.04.003
R
Ruklanthi de Alwis
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
2.9K
Citations
25
h-index
39
i10-index
Ruklanthi de Alwis is an academic researcher from National University of Singapore. The author has contributed to research in topics: Mosquito-borne diseases and control & Viral Infections and Vectors & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 25, co-authored 63 publications.
ORCID: 0000-0002-2319-3701Papers by this author
worksA highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
2015 · Nature Communications · 196 citations
https://doi.org/10.1038/ncomms7341
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
2022 · Med · 56 citations
https://doi.org/10.1016/j.medj.2021.12.004
Advancing pathogen genomics in resource-limited settings
2023 · Cell Genomics · 55 citations
https://doi.org/10.1016/j.xgen.2023.100443
Phenotype and functionality of follicular helper T cells in patients with acute dengue infection
2020 · Journal of Biomedical Science · 23 citations
https://doi.org/10.1186/s12929-020-00641-2
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine
2022 · npj Vaccines · 16 citations
https://doi.org/10.1038/s41541-022-00573-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat